Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kunlishu Kushen gel plus fluconazole for vulvovaginal candidiasis
ChiCTR2400086257Phase 4Not yet recruiting
- Sponsor
- Beijing Obstetrics and Gynecology Hospital
- Start
- Jun 2024
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in vulvovaginal candidiasis (VVC) comparing Treatment group: fluconazole + Kunlishu Kushen gel with Control group: fluconazole + Kushen gel placebo (2 arms). Primary endpoint: Itch disappearance time. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
kushen gel
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on ChiCTR2400086257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086257.